tirzepatide being discontinued The Impact of New FDA Regulations on Compounded GLP-1 - Semaglutide &

Studies can assess whether KLOW Blend can reduce symptoms in people with gluten response or celiac disease who are exposed to gluten

Focus on: Diet: A diet lower in salt helps GLP-1 medications work better

ongoing monitoring is still needed Bariatric surgery may be considered for severe obesity Medications First-line medication Reduces CSF production Start low, increase gradually Side effects: tingling, carbonated drinks taste flat, kidney stones Alternative or addition to acetazolamide May help with headache Can cause weight loss (advantage in IIH) Side effects: cognitive slowing, tingling Furosemide Sometimes added to acetazolamide Monitor potassium GLP-1 Receptor Agonists (Emerging Treatment) GLP-1 medications (such as semaglutide, sold as Ozempic or Wegovy) are showing significant promise for IIH

No trial arm, no sub-study, no exploratory analysis tested five-day dosing intervals